Literature DB >> 20064993

Rubella seroepidemiology and catch-up immunization among pregnant women in Taiwan: comparison between women born in Taiwan and immigrants from six countries in Asia.

Ching-Chiang Lin1, Chun-Yuh Yang, Ching-Tang Shih, Bai-Hsiun Chen, Yeou-Lih Huang.   

Abstract

Rubella vaccination in Taiwan started in 1986; mass vaccination was introduced into the national immunization program in 1992. In recent years, 17-31% of all marriages in Taiwan have been between Taiwanese men and foreign women. The aim of this study was to analyze rubella seroepidemiology and the rate of catch-up immunization in women. We recruited 10,089 pregnant women, including 1,920 immigrants, who had received prenatal examinations during 1999-2006. The rates of seronegativity among global, Taiwan-born, and non-Taiwan-born pregnant women were 14.0%, 11.9%, and 23.1%, respectively. The seronegativity of rubella antibodies decreased from 28.2% for Taiwan-born women born before September 1971 to 8.0% for those born thereafter. The rates of rubella catch-up immunization among global, Taiwan-born, and non-Taiwan-born pregnant women were 28.6%, 20.5%, and 42.2%, respectively. Our results suggest that substantial numbers of older Taiwan-born women and immigrant women remain susceptible to rubella infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20064993      PMCID: PMC2803507          DOI: 10.4269/ajtmh.2010.09-0302

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  11 in total

1.  Seroepidemiology study of rubella antibodies among pregnant women from seven Asian countries: evaluation of the rubella vaccination program in Taiwan.

Authors:  Hung-Fu Tseng; Chen-Kang Chang; Hsiu-Fen Tan; Shu-Er Yang; Hsueh-Wei Chang
Journal:  Vaccine       Date:  2006-05-04       Impact factor: 3.641

2.  Seroprevalence of rubella among women of childbearing age in Taiwan after nationwide vaccination.

Authors:  Shih-Bin Su; How-Ran Guo
Journal:  Am J Trop Med Hyg       Date:  2002-11       Impact factor: 2.345

3.  Factors associated with low immunity to rubella infection on antenatal screening.

Authors:  Deshanie Sathanandan; Leena Gupta; Bette Liu; Alison Rutherford; Jennifer Lane
Journal:  Aust N Z J Obstet Gynaecol       Date:  2005-10       Impact factor: 2.100

4.  Seroprevalence of rubella infection after national immunization program in Taiwan: vaccination status and immigration impact.

Authors:  I-Jen Wang; Li-Ming Huang; Hsiu-Hsi Chen; Kung-Chang Hwang; Chien-Jen Chen
Journal:  J Med Virol       Date:  2007-01       Impact factor: 2.327

Review 5.  Rubella.

Authors:  Jennifer M Best
Journal:  Semin Fetal Neonatal Med       Date:  2007-03-02       Impact factor: 3.926

6.  Congenital rubella syndrome: a risk in immigrant populations.

Authors:  E Sheridan; C Aitken; D Jeffries; M Hird; P Thayalasekaran
Journal:  Lancet       Date:  2002-02-23       Impact factor: 79.321

7.  Seroepidemiology of rubella virus infection among female residents on the offshore islets of Taiwan.

Authors:  D B Lin; C J Chen
Journal:  J Trop Med Hyg       Date:  1994-04

8.  Outcome of asymptomatic infection with rubella virus during pregnancy.

Authors:  J E Cradock-Watson; M K Ridehalgh; M J Anderson; J R Pattison
Journal:  J Hyg (Lond)       Date:  1981-10

9.  Rubella immune status of indigenous and immigrant pregnant women in Catalonia, Spain.

Authors:  Angela Dominguez; Pere Plans; Jordi Espuñes; Josep Costa; Nuria Torner; Neus Cardeñosa; Antoni Plasencia; Lluís Salleras
Journal:  Eur J Public Health       Date:  2007-04-18       Impact factor: 3.367

10.  Hepatitis B virus infection among pregnant women in Taiwan: comparison between women born in Taiwan and other southeast countries.

Authors:  Ching-Chiang Lin; Hsiu-Shu Hsieh; Yu-Jie Huang; Yeou-Lih Huang; Ming-Kun Ku; Hsin-Chia Hung
Journal:  BMC Public Health       Date:  2008-02-07       Impact factor: 3.295

View more
  7 in total

1.  Persistence and titer changes of rubella virus antibodies in primiparous women who had been vaccinated with strain RA 27/3 in junior high school.

Authors:  Ching-Chiang Lin; Chun-Yuh Yang; Yung-Luen Shih; Yang-Yang Huang; Tsung-Han Yang; Jin-Yuan Liang; Chu-Fen Chang; Hsiu-Shu Hsieh; Yeou-Lih Huang
Journal:  Clin Vaccine Immunol       Date:  2011-11-09

2.  Rubella Immunity in Pregnant Native Taiwanese and Immigrants from Asian Countries.

Authors:  Yeong-Hwa Zen; Ching-Tang Shih; Wan-Ju Kung; Chien-Hung Lee; Ching-Chiang Lin
Journal:  Am J Trop Med Hyg       Date:  2016-11-28       Impact factor: 2.345

3.  Sero-survey of rubella IgM antibodies among children in Jos, Nigeria.

Authors:  Surajudeen A Junaid; King J Akpan; Atanda O Olabode
Journal:  Virol J       Date:  2011-05-19       Impact factor: 4.099

4.  Seroepidemiology of Rubella in Women Under 25 Years Old Attending Medical Centers in Ahvaz, Iran in 2013.

Authors:  Mehri Ghafourian; Abdolhussein Shakunia; Seyed Mohammad Alavi; Wesam Kooti; Ghodratollahe Shakerinejad; Amirarsalan Serajian; Zahra Chinipardaz
Journal:  Jundishapur J Microbiol       Date:  2015-12-26       Impact factor: 0.747

5.  Phylogeography of rubella virus in Asia: Vaccination and demography shape synchronous outbreaks.

Authors:  Brooke A Bozick; Colin J Worby; C Jessica E Metcalf
Journal:  Epidemics       Date:  2019-05-28       Impact factor: 4.396

6.  Epidemiology and aetiology of maternal bacterial and viral infections in low- and middle-income countries.

Authors:  Prasad Palani Velu; Courtney A Gravett; Tom K Roberts; Thor A Wagner; Jian Shayne F Zhang; Craig E Rubens; Michael G Gravett; Harry Campbell; Igor Rudan
Journal:  J Glob Health       Date:  2011-12       Impact factor: 4.413

7.  Immunogenicity and safety of combined measles-mumps-rubella-varicella vaccine using new measles and rubella working seeds in healthy children in Taiwan and Singapore: a phase II, randomized, double-blind trial.

Authors:  Li-Min Huang; Bee-Wah Lee; Poh Chong Chan; Michael Povey; Ouzama Henry
Journal:  Hum Vaccin Immunother       Date:  2013-02-20       Impact factor: 3.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.